Open access · OA via OpenAlex

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz

Drugs · 2017 · ▲ 1,205 citations

Altered intercellular communication Chronic inflammation

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1007/s40265-017-0701-9
Canonical: link ↗
Fetched: 2026-07-28 MST

Cite this

APA

Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D.M. (2017). JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. <em>Drugs</em>. https://doi.org/10.1007/s40265-017-0701-9

Vancouver

Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs. 2017. doi:10.1007/s40265-017-0701-9.

BibTeX

@article{shubhasree2017JAKSTA, title = {JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects}, author = {Shubhasree Banerjee and Ann Biehl and Massimo Gadina and Sarfaraz Hasni and Daniella M. Schwartz}, journal = {Drugs}, year = {2017}, doi = {10.1007/s40265-017-0701-9}, }